ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its Diamondback 360 Coronary Orbital Atherectomy System (OAS).
Professor Nicolas Van Mieghem, Director of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands, who successfully treated the first European patient, said, Patients with calcific coronary artery disease have poor clinical results. Diamondback 360 Coronary OAS streamlines treatment with a unique mechanism to successfully modify severe calcium and optimize stent performance. Im confident European physicians will like this fascinating technology to help treat their patients with calcific coronary artery disease.
Orbital atherectomy has demonstrated clinical advantages compared to historical rotational atherectomy data, including lower rates of target lesion revascularization and persistent slow flow/no reflow. CSIs ORBIT II and COAST clinical studies demonstrated that OAS is safe and effective in treating patients with de novo severely calcified coronary lesions. Two real-world studies with approximately 1000 patients have reinforced Diamondbacks safety, high procedural success and long term clinical success.
CSI received CE Mark for the Diamondback 360 Coronary OAS in January 2021. Diamondback is FDA approved and has been sold in the United States since 2013.
Scott Ward, Chairman, President and Chief Executive Officer of CSI, said, We are excited to announce the first commercial use of the Diamondback 360 Coronary OAS in Europe. The introduction of this device gives physicians in Europe an effective treatment option for this difficult-to-treat patient population. We are prepared to launch the product leveraging streaming platforms to train and support physicians and their cath lab teams remotely until travel may resume.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The companys orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit http://www.csi360.com and connect on Twitter @csi360.
Safe Harbor
Certain statements in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are provided under the protection of the safe harbor for forward-looking statements provided by that Act. For example, statements in this press release regarding the commercial launch of the Diamondback 360 Coronary OAS in Europe (including the timing, scope and methods thereof), and the benefits of this product, are forward-looking statements. These statements involve risks and uncertainties that could cause results to differ materially from those projected, including, but not limited to, the reluctance of physicians, hospitals and other organizations to accept new products; the effectiveness of these products; the efforts of us and our distribution partners in launching this product; the impact of competitive products and pricing; approval of products for reimbursement and the level of reimbursement; general economic conditions; international trade developments; the ongoing COVID-19 pandemic and the impact and scope thereof on CSI, our distribution partners, the supply chain, and physicians and facilities in Europe, including government actions related to the COVID-19 outbreak, material delays and cancellations of procedures, delayed spending by healthcare providers, and distributor and supply chain disruptions; and other factors detailed from time to time in CSIs SEC reports, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. CSI encourages you to consider all of these risks, uncertainties and other factors carefully in evaluating the forward-looking statements contained in this release. As a result of these matters, changes in facts, assumptions not being realized or other circumstances, CSI's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this release. The forward-looking statements made in this release are made only as of the date of this release, and CSI undertakes no obligation to update them to reflect subsequent events or circumstances.
U.S. Diamondback 360 Coronary Orbital Atherectomy System
Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions.
Contraindications: The OAS is contraindicated when the ViperWire guide wire cannot pass across the coronary lesion or the target lesion is within a bypass graft or stent. The OAS is contraindicated when the patient is not an appropriate candidate for bypass surgery, angioplasty, or atherectomy therapy, or has angiographic evidence of thrombus, or has only one open vessel, or has angiographic evidence of significant dissection at the treatment site and for women who are pregnant or children.
Warnings/Precautions: Performing treatment in excessively tortuous vessels or bifurcations may result in vessel damage; The OAS was only evaluated in severely calcified lesions, A temporary pacing lead may be necessary when treating lesions in the right coronary and circumflex arteries; On-site surgical back-up should be included as a clinical consideration; Use in patients with an ejection fraction (EF) of less than 25% has not been evaluated.
See the instructions for use for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information call CSI at 1-877-274-0901 and/or consult CSIs website at http://www.csi360.com.
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.
The Diamondback 360 Coronary OAS is FDA PMA approved.
See the rest here:
First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360 Coronary Orbital Atherectomy System - Business Wire
- Interventional Cardiology Fellowship - Massachusetts General Hospital ... - April 8th, 2018 [April 8th, 2018]
- Dr. Eric Lo - Daytona Beach FL, Interventional Cardiology - April 18th, 2018 [April 18th, 2018]
- Interventional Cardiology | Cardiology Associates of East ... - April 19th, 2018 [April 19th, 2018]
- ECU Interventional Cardiology Fellowship - May 26th, 2018 [May 26th, 2018]
- Interventional Cardiology | Knoxville Heart Group - June 6th, 2018 [June 6th, 2018]
- Interventional Cardiology Fellowship - Massachusetts ... - June 14th, 2018 [June 14th, 2018]
- Scottsdale Interventional Forum | Cardiology Conference ... - June 21st, 2018 [June 21st, 2018]
- Interventional Cardiology - Terumo Europe - August 12th, 2018 [August 12th, 2018]
- Interventional Cardiology Fellowship | Cardiovascular Fellowship - September 20th, 2018 [September 20th, 2018]
- Interventional > Cardiovascular Medicine | Internal Medicine ... - September 20th, 2018 [September 20th, 2018]
- Interventional Cardiology Journal | Peer reviewed Journal - September 24th, 2018 [September 24th, 2018]
- Interventional Cardiology | North Florida Regional Medical ... - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | Department of Medicine ... - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | Medical City Fort Worth - October 4th, 2018 [October 4th, 2018]
- Cardiology and Interventional Cardiology | Texas Tech ... - October 4th, 2018 [October 4th, 2018]
- Invasive & Interventional Cardiology Section | Cleveland Clinic - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology - Crozer-Keystone Health System - PA - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology - Florida Medical Clinic - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | Heart Hospital of New Mexico - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | ColumbiaDoctors - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiologist Jobs | Glassdoor - October 4th, 2018 [October 4th, 2018]
- What are Invasive, Non-Invasive, and Interventional Cardiology? - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology Fellowship | Internal Medicine - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology | Community Health Network - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology | Ohio State Medical Center - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology | Stanford Health Care - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology - Montefiore Medical Center - November 10th, 2018 [November 10th, 2018]
- Interventional Cardiologists near Brooklyn, NY - Healthgrades - November 10th, 2018 [November 10th, 2018]
- Cardiac Catheterization | Interventional Cardiology in New ... - November 20th, 2018 [November 20th, 2018]
- What are Invasive, Non-Invasive, and Interventional ... - November 27th, 2018 [November 27th, 2018]
- Dr. Jaffar A Raza - Secaucus NJ, Interventional Cardiology - November 30th, 2018 [November 30th, 2018]
- Interventional cardiology - Wikipedia - December 13th, 2018 [December 13th, 2018]
- Interventional Cardiology | St. Francis - December 21st, 2018 [December 21st, 2018]
- Interventional Cardiologists near Secaucus, NJ - Healthgrades - December 21st, 2018 [December 21st, 2018]
- Interventional Cardiology Conferences & Meetings - December 25th, 2018 [December 25th, 2018]
- Interventional Cardiology - Baylor Heart and Vascular Hospital - January 18th, 2019 [January 18th, 2019]
- Interventional Cardiology - nationwidechildrens.org - January 18th, 2019 [January 18th, 2019]
- General & Interventional Cardiology - WakeMed - January 18th, 2019 [January 18th, 2019]
- Interventional Cardiology - University of Mississippi Medical ... - January 18th, 2019 [January 18th, 2019]
- Interventional Cardiologists in Austin, TX | Austin Heart - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | Sutter Health - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology - St. Mary's Hospital and Health ... - February 22nd, 2019 [February 22nd, 2019]
- London & Milan - Cardiology Fellowships - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | Saint Luke's Health System - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | American Medical Association - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | Piedmont Heart Institute ... - March 12th, 2019 [March 12th, 2019]
- Interventional Cardiology | UCSF Cardiology - March 18th, 2019 [March 18th, 2019]
- If You Are Referred to an Interventional Cardiologist - April 1st, 2019 [April 1st, 2019]
- Cardiology and Interventional Medicine | Veterinary ... - April 5th, 2019 [April 5th, 2019]
- Interventional Cardiology | AdventHealth Cardiovascular ... - May 11th, 2019 [May 11th, 2019]
- APSIC - Asian Pacific Society of Interventional Cardiology - May 13th, 2019 [May 13th, 2019]
- Interventional Cardiology | UNC REX Healthcare | Raleigh ... - May 20th, 2019 [May 20th, 2019]
- Interventional Cardiology - montefiore.org - May 20th, 2019 [May 20th, 2019]
- Women and heart health: Heart attack signs and symptoms to know about - The Indian Express - September 26th, 2019 [September 26th, 2019]
- Tiara for Treatment of Mitral Regurgitation and Neovasc Reducer for Treatment of Refractory Angina to be Featured at TCT 2019 Conference - Canada... - September 26th, 2019 [September 26th, 2019]
- TherOx to Present on SuperSaturated Oxygen (SSO2) at TCT2019 Next Week - BioSpace - September 26th, 2019 [September 26th, 2019]
- Too tired? it can indicate heart failure - The New Indian Express - September 26th, 2019 [September 26th, 2019]
- Blue Sail Medical and Biosensors International enter the Structural Heart market with the acquisition of Switzerland based NVT AG. content= - PR... - September 26th, 2019 [September 26th, 2019]
- Global Diagnostic Interventional Cardiology Instruments Market forecast by 2025 : Numerous tactics accepted by industry participants in a bid to... - September 26th, 2019 [September 26th, 2019]
- UMA's Complete Conference Management Hosts "Full Spectrum of Heart Failure Therapy: Optimizing Outcomes" - Yahoo Finance - September 26th, 2019 [September 26th, 2019]
- Meet the best cardiologists at King's Interactive Heart Health Morning - Gulf News - September 26th, 2019 [September 26th, 2019]
- Lights, camera, action in Varnville - Bluffton Today - September 26th, 2019 [September 26th, 2019]
- Health Pro: Cardiologist takes pleasure in getting patients back on their feet - Florida Today - September 26th, 2019 [September 26th, 2019]
- From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection - TCTMD - September 26th, 2019 [September 26th, 2019]
- Robocath Successfully Carries Out Its First Robotic Coronary Angioplasties in Humans - TCTMD - September 26th, 2019 [September 26th, 2019]
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ABIOMED, Inc. of Class Action Lawsuit and Upcoming... - September 28th, 2019 [September 28th, 2019]
- Study links childhood obesity with screen time - The Hindu - September 28th, 2019 [September 28th, 2019]
- Tiara for Treatment of Mitral Regurgitation and Neovasc Reducer for Treatment of Refractory Angina to be Featured at TCT 2019 Conference - BioSpace - September 28th, 2019 [September 28th, 2019]
- Five Atlantic Health System Team Members Lauded by NJ American Heart Association for Life-Saving Measures - TAPinto.net - September 28th, 2019 [September 28th, 2019]
- World Heart Day 2019: Cardiovascular Disease Is The World's Biggest Killer And Claims More Than 17.5 Million Lives - Outlook India - September 28th, 2019 [September 28th, 2019]
- Consulting Cardiologists Brings Exceptional Care to Heart of WH - Patch.com - September 28th, 2019 [September 28th, 2019]
- Diagnostic Interventional Cardiology Devices Market 2019| Global Forecast to 2026 with Key Players- B. Braun Medical, Boston Scientific, Cook Medical,... - September 28th, 2019 [September 28th, 2019]
- Surmodics Inc. (SRDX) and Its Competitors Comparing side by side. - MS Wkly - October 17th, 2019 [October 17th, 2019]
- Global Price, Sales and Revenue Analysis of Diagnostic Interventional Cardiology Devices Market by Regions, Manufacturers, Types and Applications -... - October 17th, 2019 [October 17th, 2019]
- Global Interventional Cardiology Devices Market Study by Price, Type and Application, Statistical Forecast and Competitive Landscape Research upto... - October 17th, 2019 [October 17th, 2019]
- Global Interventional Cardiology Market Report, Trends, CAGR Standing, Analysis and Forecasts (2019-2025) | Key Companies BIOTRONIK SE & Co.... - October 17th, 2019 [October 17th, 2019]
- Interventional Cardiology Market 2019 to Flourish with an Impressive CAGR of XX% in the year 2024, Predicts Market Research Future According to... - October 17th, 2019 [October 17th, 2019]
- FDA Approves Coronary ViperWire Advance With Flex Tip - Diagnostic and Interventional Cardiology - October 23rd, 2019 [October 23rd, 2019]
- Teleflex Announces Third Quarter 2019 Earnings Conference Call Information Live Webcast is scheduled at 8:00 am (ET) on Thursday, October 31, 2019 -... - October 23rd, 2019 [October 23rd, 2019]
- Global Interventional Cardiology Devices Market Analysis and CAGR during the Forecasting years of 2019-2025. - Air News Paper - October 23rd, 2019 [October 23rd, 2019]